CD8A and COVID-19: However, there is still not a consensus on the involvement of the cross-reactive response in the clinical outcome, although recent studies have pointed to a role for cross-reactive CD8 T-cell responses in protection from SARS-CoV-2 infection [70] and severe COVID-19 [84].